Cargando…
PPARγ Deacetylation Confers the Antiatherogenic Effect and Improves Endothelial Function in Diabetes Treatment
Cardiovascular disease (CVD) is the leading cause of death in patients with diabetes, and tight glycemic control fails to reduce the risk of developing CVD. Thiazolidinediones (TZDs), a class of peroxisome proliferator–activated receptor γ (PPARγ) agonists, are potent insulin sensitizers with antiat...
Autores principales: | Liu, Longhua, Fan, Lihong, Chan, Michelle, Kraakman, Michael J., Yang, Jing, Fan, Yong, Aaron, Nicole, Wan, Qianfen, Carrillo-Sepulveda, Maria Alicia, Tall, Alan R., Tabas, Ira, Accili, Domenico, Qiang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372079/ https://www.ncbi.nlm.nih.gov/pubmed/32409492 http://dx.doi.org/10.2337/db20-0217 |
Ejemplares similares
-
Impaired MEK Signaling and SERCA Expression Promote ER Stress and Apoptosis in Insulin-Resistant Macrophages and Are Reversed by Exenatide Treatment
por: Liang, Chien-Ping, et al.
Publicado: (2012) -
PPARδ Activation Protects Endothelial Function in Diabetic Mice
por: Tian, Xiao Yu, et al.
Publicado: (2012) -
Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models
por: Chen, Ying, et al.
Publicado: (2013) -
Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis
por: Cheng, Rui, et al.
Publicado: (2016) -
Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPARα
por: Chen, Qian, et al.
Publicado: (2017)